Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

Bert Gold1, Joanna E Merriam, Jana Zernant

  • 1Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland 21702, USA.

Nature Genetics
|March 7, 2006
PubMed

Insights

Genetic variations in factor B (BF) and complement component 2 (C2) genes are linked to age-related macular degeneration (AMD) risk. Specific BF and C2 haplotypes significantly reduce AMD risk, improving prediction when combined with CFH variants.

Area of Science:

  • Genetics
  • Ophthalmology
  • Immunology

Background:

  • Age-related macular degeneration (AMD) is a leading cause of irreversible blindness globally.
  • Complement factor H (CFH) gene variants are known risk factors for AMD.
  • The alternative complement pathway plays a crucial role in AMD pathogenesis.

Purpose of the Study:

  • To investigate the association of genetic variations in factor B (BF) and complement component 2 (C2) genes with AMD risk.
  • To identify specific haplotypes within BF and C2 that confer risk or protection against AMD.
  • To assess the combined predictive power of CFH, BF, and C2 variants for AMD clinical outcomes.

Main Methods:

  • Screening of BF and C2 genes for genetic variation in two independent cohorts.
  • Analysis of approximately 900 individuals with AMD and 400 matched controls.
  • Haplotype analyses to identify risk and protective genetic variants.

Main Results:

  • A common risk haplotype (H1) and two protective haplotypes were identified in BF and C2.
  • Specific BF (L9H) and C2 (E318D) variants (haplotype H10) significantly reduced AMD risk (OR=0.45).
  • A C2 intron 10 variant combined with BF R32Q variant (haplotype H7) also significantly reduced AMD risk (OR=0.36).

Conclusions:

  • Genetic variations in BF and C2 are associated with AMD risk, expanding the known genetic factors.
  • Combined analysis of CFH, BF, and C2 variants can predict AMD clinical outcomes with substantial accuracy.
  • These findings refine the understanding of the complement system's role in AMD pathogenesis and genetic risk.

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Complementation Tests00:49

Complementation Tests

A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...